ThursdayJun 03, 2021 2:00 pm

Researchers Discover Link Between Alzheimer’s, BMI

A recent study conducted by researchers from Ohio State University has found that a higher BMI doesn’t necessarily increase an individual’s chance of developing Alzheimer’s disease. This is despite the fact that obesity in mid-life has been associated with a higher risk of Alzheimer’s. For their research, the scientists compared data obtained from two groups of individuals who had been diagnosed with mild cognitive impairment. One group’s disease didn’t worsen while the other’s condition progressed to Alzheimer’s within two years. The scientists focused on two factors: various genetic variants that have been linked to Alzheimer’s and body mass index (“BMI”).…

Continue Reading

ThursdayJun 03, 2021 9:00 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Targets Academic Collaborations to Advance Research on Largely Ignored Indications for Psilocybin

Psychedelics have been on the receiving end of groundbreaking research, which have greatly influenced the medical acceptance of the compounds Pharmaceutical developer Tryp Therapeutics is looking to use existing preclinical and clinical data to proceed directly to Phase 2a clinical trials The company intends to contribute to the growing body of research through academic collaborations with leading American institutions  The research will focus on indications that other pharmaceutical companies have largely ignored Although we can accurately describe the psychedelics industry as nascent, psychedelics have been the subject of a flurry of groundbreaking research that have gradually lifted the stigma surrounding…

Continue Reading

WednesdayJun 02, 2021 2:32 pm

New Immunotherapy May Improve Stroke Recovery

A recent study conducted by neurologists from the School of Medicine at the University of Pittsburg has discovered that immune cells that amass in the brain following a stroke help boost neural functions, as observed in mice models. The research, which was reported in the “Immunity” journal, showed that regulatory T cells, which are specialized immune cells, help boost functional recovery following a stroke. The researchers stated that boosting the regulatory T cell levels through the use of an antibody complex treatment enhanced cognitive and behavioral functions in mice following a stroke. This was in comparison to the mice that…

Continue Reading

WednesdayJun 02, 2021 9:30 am

Healthy Extracts Inc. (HYEX) Using HERHEART(TM) Supplement to Address the Cardiovascular Disease Headache among Women

Cardiovascular disease is the leading cause of mortality among women globally and in the US Using this knowledge as the motivation, Healthy Extracts, through its wholly owned subsidiary BergaMet NA, developed HERHEART(TM) HERHEART is derived from the bergamot fruit, richly packed with polyphenols, and is formulated specifically for women to improve heart health and perimenopausal symptoms Polyphenols have antioxidant and anti-inflammatory properties and are associated with improved heart health, as well as the prevention of some heart-related conditions Through HERHEART product, Healthy Extracts is playing a vital preventative role in the fight against cardiovascular disease among women Cardiovascular disease is…

Continue Reading

WednesdayJun 02, 2021 9:15 am

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Beginning 2021 Strong with New Drugs and Life Sciences Advancements

Promising results have been recorded in the first pilot study of a Rotigotine skin patch for Parkinson’s patients Wholly owned subsidiary Vektor is reaching a major milestone in the development of Rotigotine with the potential for a pivotal human trial The company is planning the construction of a new lab and manufacturing space up to 32,000 square feet in Biberach, Germany Pilot project involving rapid COVID-19 PCR tests has been initiated in Germany, promising efficacy and accuracy of results in as little as 25 minutes XPhyto is currently in talks and negotiations with distribution and wholesale partners, with a potential…

Continue Reading

TuesdayJun 01, 2021 1:00 pm

Mathematical Models Show COVID-19 May Become Seasonal Virus Within a Decade

Recent research conducted by researchers from the University of Utah has found that in the next 10 years, the SARS-CoV-2 virus, which is responsible for the coronavirus, may cause no more than sniffles and coughs similar to the common cold. The researchers used mathematical models to predict how the body’s immunity changes over time. Their findings were reported in the “Viruses” journal. Fred Adler, a professor of biological sciences and mathematics at the institution, explained that the models demonstrated a possible future that is yet to be addressed fully. He added that as people collectively develop immunity over the next…

Continue Reading

FridayMay 28, 2021 12:15 pm

DGE’s 2-Day Omnichannel Marketing Strategy Symposium To Offer Skills To Elevate Customized Consumer Experience

Live Streaming Event June 10th-11th 2021 On June 10-11, 2021, life science professionals are invited to attend DGE’s Omnichannel Marketing Strategy Symposium to learn skills and techniques for developing a personalized marketing strategy for consumers. The event is hosted by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events. The Global Event Company caters to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries. As marketing gets personalized and consumers expect to be reached on their channel of preference, pharma companies are spending significantly on marketing and sales. But, do all pharma…

Continue Reading

FridayMay 28, 2021 11:30 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Building Psychedelic Medicine Program on Foundation of Strong Leadership, Pharmaceutical Alliances

Pharmaceutical developer Tryp Therapeutics is focused on producing novel bioscience solutions for conditions with unmet needs Tryp’s current flagship program involves development of a synthetic psychedelic drug candidate for treating specific pain and eating disorder indications The company expects to begin manufacturing its initial oral psilocybin formulation in September 2021 Tryp’s scientific and executive team has decades of experience in large pharma, emerging pharma, drug approvals, psychedelics and capital markets to draw on in developing its product The company is also working with pharmaceutical partners whose diversity of experience will provide support for Tryp’s path to oral psilocybin development Bio-pharmaceutical…

Continue Reading

FridayMay 28, 2021 10:00 am

UM Twin Cities Researchers Find Way to Optimize Immune Response Against Cancer

In what many have described as groundbreaking work, a team of researchers based at University of Minnesota Twin Cities has demonstrated how the body’s immune cells can be engineered in order to navigate the physical barriers that make it hard for an individual’s immune system to fight cancerous tumors. This study has the potential to improve how millions of cancer patients are treated. The research paper was published in the journal “Nature Communications.” Conventionally, cancers are commonly treated through the use of chemicals (chemotherapy), radiation and surgery. Combinations of these approaches are also common. However, immunotherapy is also gaining ground…

Continue Reading

FridayMay 28, 2021 9:00 am

Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary Highlights, Q1 Financials Herald Bright Horizon for Company

POAI announced that total stockholders’ equity increased by nearly $33 million to $35.5 million Financial report notes net proceeds of $35.6 million from private placement, direct offering, warrant exercises Company subsidiaries reached several milestone achievements throughout the quarter. Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, reported its financial results for first quarter 2021, the period ending March 31, 2021 (https://ibn.fm/kUVwH). The company also released key business updates along with its financial numbers.  “The combination of equity transactions and retirement of our outstanding debt has brought significant value to…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000